摘要
目的阐明中国胰腺癌患者K-ras基因12密码子突变频率,为临床应用打下基础。方法两轮PCR-RFLP技术对32例石蜡包埋胰腺癌标本和15例阴性对照作基因分析。结果32例胰腺癌标本中30例检测到K-ras基因12密码子突变,阳性率为93.8%,而15例阴性对照无1例检测到突变。结论中国胰腺癌患者K-ras基因12密码子突变率高达90%左右,该突变的有无可作为在基因水平上鉴别诊断胰腺癌的一个可靠标志。
Objective To investigate the mutation rate of K-ras codon 12 in Chinese patients with pancreatic adenocarcinoma and assess its value for clinical application.Method 32 paraffin-embedded specimens of pancreatic adenocarcinoma and 15 negative controls were analysed at gene level by using double PCR-RFLP.Result K-ras codon 12 mutation was present in 30 out of 32 cases of pancreatic adenocarcinoma,the positive rate was 93.8%,whereas no mutation was detected in the 15 negative controls.Conclution The mutation rate of K-ras codon 12 is up to about 90% in pancreatic adenocarcinomas in China and this mutation may serve as a reliable marker for distinguishing and diagnosing pancreatic adenocarcinoma at gene level.
出处
《徐州医学院学报》
CAS
1997年第6期20-22,共3页
Acta Academiae Medicinae Xuzhou
基金
江苏省教委自然科学基金
关键词
胰腺肿瘤
RAS基因
突变
限制性片段长度多态性
Pancreatic neoplasms ras genes Mutation Restriction fragment length polymorphism